Roivant Sciences Ltd. (ROIV)

Roivant Sciences Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	1,991	6,536	1,677	2,060	2,055	2,183
Cash & Short-Term Investments	5,147	6,536	1,677	2,060	2,055	2,183
Cash Growth	-22.85%	289.77%	-18.62%	0.26%	-5.87%	157.19%
Accounts Receivable	0.68	53.55	30.38	3.88	-	3.67
Other Receivables	143.1	29.27	7.27	2.85	-	6.61
Receivables	143.78	82.81	37.64	6.73	-	15.28
Inventory	-	35.25	2.76	-	-	-
Prepaid Expenses	57.66	55.1	60.83	53.37	-	16.34
Restricted Cash	3.1	5.37	5.01	3.9	77.7	2.28
Other Current Assets	12.92	17.6	15.53	22.12	54.25	2.14
Total Current Assets	5,364	6,732	1,799	2,147	2,187	2,219
Property, Plant & Equipment	104.46	65.95	92.34	86.95	77.03	73.93
Long-Term Investments	290.04	247.75	304.32	325.83	289.54	93.45
Other Intangible Assets	-	137.84	144.88	-	-	-
Other Long-Term Assets	33.88	39.11	49.48	25.82	36.13	90.43
Total Assets	5,792	7,222	2,390	2,585	2,590	2,477
Accounts Payable	23.71	53.23	37.83	34.58	20.55	10.31
Accrued Expenses	104.32	175.59	167.13	127.53	76.94	68.62
Current Portion of Long-Term Debt	-	12	40.72	-	-	-
Current Portion of Leases	9.84	9.89	11.69	11.4	12.31	7.84
Current Income Taxes Payable	0.58	10.47	0.54	0.71	-	1.5
Current Unearned Revenue	3.04	4.17	12.44	10.15	5.92	3.62
Other Current Liabilities	-	1.42	2.09	-	103.24	0.23
Total Current Liabilities	141.48	266.76	272.45	184.37	218.96	92.12
Long-Term Debt	-	430.59	375.52	210.03	170.28	108.59
Long-Term Leases	90.48	47.27	53.48	62.47	62.38	64.45
Other Long-Term Liabilities	24.41	29.34	80.58	66.84	76.06	103.19
Total Liabilities	256.38	773.95	782.02	523.7	527.69	368.36
Additional Paid-In Capital	4,721	5,396	4,933	4,422	3,815	3,144
Retained Earnings	460.4	576.17	-3,773	-2,764	-1,918	-1,109
Comprehensive Income & Other	8.06	-4.08	-2.62	-0.95	-98.56	-2.35
Total Common Equity	5,189	5,969	1,158	1,657	1,798	2,032
Minority Interest	346.5	479.95	449.82	404.49	264.22	76.53
Shareholders' Equity	5,536	6,449	1,608	2,061	2,062	2,109
Total Liabilities & Equity	5,792	7,222	2,390	2,585	2,590	2,477
Total Debt	100.31	499.75	481.4	283.89	244.98	180.88
Net Cash (Debt)	5,046	6,036	1,195	1,777	1,810	2,002
Net Cash Growth	-18.14%	404.93%	-32.71%	-1.85%	-9.60%	183.74%
Net Cash Per Share	6.74	7.26	1.68	2.65	2.87	9.14
Filing Date Shares Outstanding	713.55	738.72	766.81	700.77	222.67	214.88
Total Common Shares Outstanding	719.63	806.68	760.14	694.98	222.67	214.88
Working Capital	5,222	6,465	1,526	1,962	1,968	2,127
Book Value Per Share	7.21	7.40	1.52	2.38	8.07	9.46
Tangible Book Value	5,189	5,831	1,013	1,657	1,798	2,032
Tangible Book Value Per Share	7.21	7.23	1.33	2.38	8.07	9.46

Source: S&P Capital IQ. Standard template. Financial Sources.